Tibetan medicine Jiuwei Qingpeng San could inhibit influenza A virus induced lung injury via regulating the expression of IFN-γ and its signaling pathway
Introduction: The Tibetan formula Jiuwei Qingpeng San (JWQPS) has been applied for severe respiratory infection with a centuries-old history and contemporarily applied for influenza induced pneumonia. Although it is empirically effective, its antiviral efficacy and the underlying mechanisms against...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-09-01
|
| Series: | Pharmacological Research - Modern Chinese Medicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667142523000465 |
| _version_ | 1827815754862428160 |
|---|---|
| author | Liu Wei Li Chufang Song Jian Li Jintao Liang Liren Cai Kaiyin Wang Yinong Chen Weiwu Chen Lvyi Hou Hongping Mingji Cuomu Zhong Nanshan |
| author_facet | Liu Wei Li Chufang Song Jian Li Jintao Liang Liren Cai Kaiyin Wang Yinong Chen Weiwu Chen Lvyi Hou Hongping Mingji Cuomu Zhong Nanshan |
| author_sort | Liu Wei |
| collection | DOAJ |
| description | Introduction: The Tibetan formula Jiuwei Qingpeng San (JWQPS) has been applied for severe respiratory infection with a centuries-old history and contemporarily applied for influenza induced pneumonia. Although it is empirically effective, its antiviral efficacy and the underlying mechanisms against influenza A (IAV) virus induced lung injury have not been elucidated yet. Methods: The in vitro anti-viral activity of JWQPS against H1N1 was reflected by the detection of cell viability of PR8 infected BEAS-2B cells. A replication competent PR8 carrying Gaussia luciferase (PR8-Luci) was further utilized to infect BEAS-2B cells to determine the inhibitory activity of virus replication by detection of the intensity of bioluminescence that correlates with viral load. Transcriptome was utilized to analyze the differences of the gene expression profiles in BEAS-2B cell line between the groups with or without JWQPS treatment after PR8 infection. BALB/c mice were intranasally inoculated with 60 or 150 p.f.u. of PR8 and intragastric administered with JWQPS (400 mg/kg/day, 200 mg/kg/day, 100 mg/kg/day). The mice infected with lethal dosages of 60 p.f.u. were monitored and weighed daily for 14 days and the survival rates were calculated. Concentrations of Nucleoprotein (NP) of IAV in BALF that stand for viral load were determined at 3 or 6 d.p.i. by enzyme linked immunosorbent assay (ELISA). Interferons and lymphotactin in the BALF collected at 3 d.p.i. were detected with the corresponding ELISA kits. The level of pro-inflammatory cytokines in BALF collected at 6 d.p.i. were detected using Th1/Th2 Cytokine 11-Plex Mouse ProcartaPlex Panel. The numbers of leukocyte in BALF were counted by an automated blood cell counter. The lung tissues of mice that were not subjected to BALF collection were harvested at 6 d.p.i. to check lung lesions by hematoxylin-eosin staining and lung coefficient calculation. Results: JWQPS inhibited IAV replication in vitro, down regulated NP in BALF of H1N1 infected BALB/c mice and protected the mice from IAV caused death. The elevated level of lymphotactin, IFN-γ and lymphocytes in BALF were observed 3 days post infection after JWQPS administration. The improved lung lesions, the alleviated leukocytes infiltration, and the decreased pro-inflammatory levels were observed 6 days post infection. Transcriptomic analysis of H1N1 infected lung epithelial cell line revealed JWQPS treatment could dramatically regulate the genes involved in defense response to virus and interferon associated signaling pathways. Discussion: Our study indicated that JWQPS could promote the chemotactic effect of lymphocytes towards site of infection to eliminate the pathogen at early phase of infection and alleviate the development of inflammation thereafter by reducing the occurrence of neutrophils and lymphocytes into the pulmonary alveoli by a rather complicated regulatory network in immune responses. |
| first_indexed | 2024-03-12T00:05:09Z |
| format | Article |
| id | doaj.art-668fe7855fc24313abfa33d15a86ca8d |
| institution | Directory Open Access Journal |
| issn | 2667-1425 |
| language | English |
| last_indexed | 2024-03-12T00:05:09Z |
| publishDate | 2023-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Pharmacological Research - Modern Chinese Medicine |
| spelling | doaj.art-668fe7855fc24313abfa33d15a86ca8d2023-09-17T04:57:53ZengElsevierPharmacological Research - Modern Chinese Medicine2667-14252023-09-018100260Tibetan medicine Jiuwei Qingpeng San could inhibit influenza A virus induced lung injury via regulating the expression of IFN-γ and its signaling pathwayLiu Wei0Li Chufang1Song Jian2Li Jintao3Liang Liren4Cai Kaiyin5Wang Yinong6Chen Weiwu7Chen Lvyi8Hou Hongping9Mingji Cuomu10Zhong Nanshan11Guangzhou Laboratory, Guangzhou, China; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, ChinaGuangzhou Laboratory, Guangzhou, China; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, ChinaGuangzhou Laboratory, Guangzhou, China; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, ChinaBeijing International Science and Technology Cooperation Base of Antivirus Drug, Beijing University of Technology, Beijing, ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, ChinaState Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, ChinaBeijing International Science and Technology Cooperation Base of Antivirus Drug, Beijing University of Technology, Beijing, ChinaTibet Cheezheng Tibet Medicine Co.,Ltd., Beijing, ChinaSchool of Pharmaceutical Sciences, South-Central Minzu University, Wuhan, ChinaInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, ChinaThe University of Tibetan Medicine, Lhasa, ChinaGuangzhou Laboratory, Guangzhou, China; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China; Corresponding author.Introduction: The Tibetan formula Jiuwei Qingpeng San (JWQPS) has been applied for severe respiratory infection with a centuries-old history and contemporarily applied for influenza induced pneumonia. Although it is empirically effective, its antiviral efficacy and the underlying mechanisms against influenza A (IAV) virus induced lung injury have not been elucidated yet. Methods: The in vitro anti-viral activity of JWQPS against H1N1 was reflected by the detection of cell viability of PR8 infected BEAS-2B cells. A replication competent PR8 carrying Gaussia luciferase (PR8-Luci) was further utilized to infect BEAS-2B cells to determine the inhibitory activity of virus replication by detection of the intensity of bioluminescence that correlates with viral load. Transcriptome was utilized to analyze the differences of the gene expression profiles in BEAS-2B cell line between the groups with or without JWQPS treatment after PR8 infection. BALB/c mice were intranasally inoculated with 60 or 150 p.f.u. of PR8 and intragastric administered with JWQPS (400 mg/kg/day, 200 mg/kg/day, 100 mg/kg/day). The mice infected with lethal dosages of 60 p.f.u. were monitored and weighed daily for 14 days and the survival rates were calculated. Concentrations of Nucleoprotein (NP) of IAV in BALF that stand for viral load were determined at 3 or 6 d.p.i. by enzyme linked immunosorbent assay (ELISA). Interferons and lymphotactin in the BALF collected at 3 d.p.i. were detected with the corresponding ELISA kits. The level of pro-inflammatory cytokines in BALF collected at 6 d.p.i. were detected using Th1/Th2 Cytokine 11-Plex Mouse ProcartaPlex Panel. The numbers of leukocyte in BALF were counted by an automated blood cell counter. The lung tissues of mice that were not subjected to BALF collection were harvested at 6 d.p.i. to check lung lesions by hematoxylin-eosin staining and lung coefficient calculation. Results: JWQPS inhibited IAV replication in vitro, down regulated NP in BALF of H1N1 infected BALB/c mice and protected the mice from IAV caused death. The elevated level of lymphotactin, IFN-γ and lymphocytes in BALF were observed 3 days post infection after JWQPS administration. The improved lung lesions, the alleviated leukocytes infiltration, and the decreased pro-inflammatory levels were observed 6 days post infection. Transcriptomic analysis of H1N1 infected lung epithelial cell line revealed JWQPS treatment could dramatically regulate the genes involved in defense response to virus and interferon associated signaling pathways. Discussion: Our study indicated that JWQPS could promote the chemotactic effect of lymphocytes towards site of infection to eliminate the pathogen at early phase of infection and alleviate the development of inflammation thereafter by reducing the occurrence of neutrophils and lymphocytes into the pulmonary alveoli by a rather complicated regulatory network in immune responses.http://www.sciencedirect.com/science/article/pii/S2667142523000465Tibetan medicineInfluenza A virusPulmonary inflammationTranscriptomeInterferon signaling pathway |
| spellingShingle | Liu Wei Li Chufang Song Jian Li Jintao Liang Liren Cai Kaiyin Wang Yinong Chen Weiwu Chen Lvyi Hou Hongping Mingji Cuomu Zhong Nanshan Tibetan medicine Jiuwei Qingpeng San could inhibit influenza A virus induced lung injury via regulating the expression of IFN-γ and its signaling pathway Pharmacological Research - Modern Chinese Medicine Tibetan medicine Influenza A virus Pulmonary inflammation Transcriptome Interferon signaling pathway |
| title | Tibetan medicine Jiuwei Qingpeng San could inhibit influenza A virus induced lung injury via regulating the expression of IFN-γ and its signaling pathway |
| title_full | Tibetan medicine Jiuwei Qingpeng San could inhibit influenza A virus induced lung injury via regulating the expression of IFN-γ and its signaling pathway |
| title_fullStr | Tibetan medicine Jiuwei Qingpeng San could inhibit influenza A virus induced lung injury via regulating the expression of IFN-γ and its signaling pathway |
| title_full_unstemmed | Tibetan medicine Jiuwei Qingpeng San could inhibit influenza A virus induced lung injury via regulating the expression of IFN-γ and its signaling pathway |
| title_short | Tibetan medicine Jiuwei Qingpeng San could inhibit influenza A virus induced lung injury via regulating the expression of IFN-γ and its signaling pathway |
| title_sort | tibetan medicine jiuwei qingpeng san could inhibit influenza a virus induced lung injury via regulating the expression of ifn γ and its signaling pathway |
| topic | Tibetan medicine Influenza A virus Pulmonary inflammation Transcriptome Interferon signaling pathway |
| url | http://www.sciencedirect.com/science/article/pii/S2667142523000465 |
| work_keys_str_mv | AT liuwei tibetanmedicinejiuweiqingpengsancouldinhibitinfluenzaavirusinducedlunginjuryviaregulatingtheexpressionofifnganditssignalingpathway AT lichufang tibetanmedicinejiuweiqingpengsancouldinhibitinfluenzaavirusinducedlunginjuryviaregulatingtheexpressionofifnganditssignalingpathway AT songjian tibetanmedicinejiuweiqingpengsancouldinhibitinfluenzaavirusinducedlunginjuryviaregulatingtheexpressionofifnganditssignalingpathway AT lijintao tibetanmedicinejiuweiqingpengsancouldinhibitinfluenzaavirusinducedlunginjuryviaregulatingtheexpressionofifnganditssignalingpathway AT liangliren tibetanmedicinejiuweiqingpengsancouldinhibitinfluenzaavirusinducedlunginjuryviaregulatingtheexpressionofifnganditssignalingpathway AT caikaiyin tibetanmedicinejiuweiqingpengsancouldinhibitinfluenzaavirusinducedlunginjuryviaregulatingtheexpressionofifnganditssignalingpathway AT wangyinong tibetanmedicinejiuweiqingpengsancouldinhibitinfluenzaavirusinducedlunginjuryviaregulatingtheexpressionofifnganditssignalingpathway AT chenweiwu tibetanmedicinejiuweiqingpengsancouldinhibitinfluenzaavirusinducedlunginjuryviaregulatingtheexpressionofifnganditssignalingpathway AT chenlvyi tibetanmedicinejiuweiqingpengsancouldinhibitinfluenzaavirusinducedlunginjuryviaregulatingtheexpressionofifnganditssignalingpathway AT houhongping tibetanmedicinejiuweiqingpengsancouldinhibitinfluenzaavirusinducedlunginjuryviaregulatingtheexpressionofifnganditssignalingpathway AT mingjicuomu tibetanmedicinejiuweiqingpengsancouldinhibitinfluenzaavirusinducedlunginjuryviaregulatingtheexpressionofifnganditssignalingpathway AT zhongnanshan tibetanmedicinejiuweiqingpengsancouldinhibitinfluenzaavirusinducedlunginjuryviaregulatingtheexpressionofifnganditssignalingpathway |